TITLE

Recent Advances in Lipid-Based Formulation Technology

AUTHOR(S)
Porter, Christopher J. H.; Williams, Hywel D.; Trevaskis, Natalie L.
PUB. DATE
December 2013
SOURCE
Pharmaceutical Research;Dec2013, Vol. 30 Issue 12, p2971
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
No abstract available.
ACCESSION #
92593258

 

Related Articles

  • Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems. Shweta Gupta; Rajesh Kesarla; Abdelwahab Omri // ISRN Pharmaceutics;2013, p1 

    Poorly water-soluble drug candidates are becoming more prevalent. It has been estimated that approximately 60-70% of the drug molecules are insufficiently soluble in aqueous media and/or have very low permeability to allow for their adequate and reproducible absorption from the gastrointestinal...

  • Comparative evaluation of various solubility enhancement strategies for furosemide. Murtaza, Ghulam; Khan, Shujaat Ali; Najam-ul-Haq, Muhammad; Hussain, Izhar // Pakistan Journal of Pharmaceutical Sciences;Jul2014, Vol. 27 Issue 4, p963 

    Drugs with good solubility exhibit good oral absorption, and subsequently good bioavailability. Thus, most exigent phase of drug development practice particularly for oral dosage forms is the enhancement of drug solubility. This review describes various traditional and novel methodologies...

  • Rate-Limiting Steps of Oral Absorption for Poorly Water-Soluble Drugs in Dogs; Prediction from a Miniscale Dissolution Test and a Physiologically-Based Computer Simulation. Ryusuke Takano; Kentaro Furumoto; Koji Shiraki; Noriyuki Takata; Yoshiki Hayashi; Yoshinori Aso; Shinji Yamashita // Pharmaceutical Research;Oct2008, Vol. 25 Issue 10, p2334 

    ABSTRACT Purpose  Nonlinear oral absorption due to poor solubility often impedes drug development. The purpose of this study was to elucidate the rate-limiting process in oral absorption of Biopharmaceutical Classification System (BCS) class II (low solubility–high permeability)...

  • A review on bio-availability enhancement techniques of poorly soluble drug. Khan, Anwar; Malviya, Rishabha; Sharma, Pramod K. // International Journal of Pharmacy;Jul2014, Vol. 4 Issue 3, p260 

    Solubility is the process of dissolution of solid in liquid phase to give a homogenous system and is one of the important parameter to achieve desired concentration of drug in systemic circulation for pharmacological response. Dissolution rate of poorly water-soluble drugs is rate limiting step...

  • Chapter 2: Pharmacokinetics I: Drug Administration, Absorption, and Distribution.  // Pharmacology in Rehabilitation;2007, p13 

    Chapter 2 of the book "Pharmacology in Rehabilitation," 4th edition is presented. It explains the administration and the physiological absorption and distribution of drugs. It describes two primary routes for drug administration, namely enteral and parenteral. The chapter also discusses the...

  • Controlling Drug Release Through Osmotic Systems. Siew, Adeline // Pharmaceutical Technology Europe;Jul2013, Vol. 25 Issue 7, p18 

    The article discusses osmosis, or the diffusion of fluids through membranes, as a way to regulate drug release determined by the generation of osmotic pressure within the center of the drug when exposed to water. Its advantages include constant delivery of the drug, delivery may be controlled...

  • SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUGS. Gohil, Tushar // Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia;2014, Vol. 25 Issue 1, p1 

    Aqueous solubility is a limiting factor in the oral bioavailability of a certain class of poorly water soluble drugs. A consequence of low aqueous solubility is a slow dissolution rate. For the drugs with low aqueous solubility and high permeability the dissolution rate will be the rate limiting...

  • Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug. Sharma1, Anshu; Jain, C.P. // International Journal of Drug Delivery;2011, Vol. 3 Issue 4, p149 

    Poorly water soluble compounds have solubility and dissolution related bioavailability problems. The present review deals in detail about solid dispersion technology and its manufacturing techniques at laboratory and industrial level. This highlight about various hydrophilic polymers used in...

  • MDR1 and OAT1/OAT3 Mediate the Drug-Drug Interaction between Puerarin and Methotrexate. Liu, Qi; Wang, Changyuan; Meng, Qiang; Huo, Xiaokui; Sun, Huijun; Peng, Jinyong; Ma, Xiaochi; Sun, Pengyuan; Liu, Kexin // Pharmaceutical Research;May2014, Vol. 31 Issue 5, p1120 

    Purpose: To conduct in vivo and in vitro experiments to investigate puerarin (PUR), an isoflavone C-glyoside, and elucidate its ability to alter methotrexate (MTX) transport and pharmacokinetics. Methods: In vivo absorption studies, in vitro everted intestinal sac preparation, kidney slices in...

Share

Other Topics